• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

LivaNova

Is Medtronic eyeing LivaNova for a takeover?

March 2, 2020 By Nancy Crotti

Some industry analysts are speculating that Medtronic (NYSE:MDT) might want to acquire LivaNova (NSDQ:LIVN) for its neuromodulation business. A source told financial intelligence company  Reorg last week that someone pitched the idea to Medtronic, which would divest LivaNova’s cardiovascular business and “certain MDT cardiac surgery products.” “Five sector advisors said such a deal would make sense as […]

Filed Under: Business/Financial News, Cardiovascular, Mergers & Acquisitions, Neuromodulation/Neurostimulation Tagged With: Boston Scientific, Edwards Lifesciences, Johnson & Johnson, LivaNova, Medtronic

LivaNova adds Verily to depression study

February 27, 2020 By Sean Whooley

LivaNova (NSDQ:LIVN) announced that it has added Google’s (NSDQ:GOOGL) Verily to its study of vagus nerve stimulation (VNS) therapy for difficult-to-treat depression (DTD). The Recover clinical will gather quantitative data on patient behavior using Verily’s technology and analytics. The data could help the researchers understand depressive episodes and the patient’s response to treatment. Study participants will […]

Filed Under: Business/Financial News, Clinical Trials, Health Technology, Neuromodulation/Neurostimulation, Software / IT Tagged With: Alphabet (Google), LivaNova, Verily

LivaNova pulls the plug on transcatheter mitral valve repair device

November 20, 2019 By Sean Whooley

LivaNova (NSDQ:LIVN) said today that it is ending its Caisson Interventional transcatheter mitral valve replacement (TMVR) program and plans to restructure its heart valve business to improve profitability. The company’s heart valve business represented nearly $130 million in revenue during fiscal 2018 and saw its revenue numbers decline over the last five years, both with biological […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Mergers & Acquisitions, News Well, Replacement Heart Valves Tagged With: caissoninterventional, LivaNova

LivaNova slumps on Q3 revenues miss

October 30, 2019 By Brad Perriello

LivaNova (NSDQ:LIVN) shares slumped in early trading today after the medical device company reported lower-than-expected third-quarter revenues, despite a swing to black ink and a health beat on earnings. London-based LivaNova posted profits of $32.1 million, or 66¢ per share, on sales of $268.6 million for the three months ended Sept. 30. That compares with losses […]

Filed Under: Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: LivaNova

LivaNova recalls VNS generators

October 10, 2019 By Nancy Crotti

LivaNova (NSDQ:LIVN) is recalling some of its Model 1000 SenTiva vagus nerve stimulation therapy (VNS) generators, which may reset themselves during therapy. A component supplied by an outside company produces an error that causes the generator to reset and fail to deliver the intended VNS therapy, according to London-based LivaNova. Resets may occur during routine […]

Filed Under: Featured, Neuromodulation/Neurostimulation, Recalls Tagged With: LivaNova

LivaNova launches vagus nerve stim depression study

September 30, 2019 By Sean Whooley

LivaNova (NSDQ:LIVN) said last week that it enrolled its first patient in a study of vagus nerve stimulation therapy for treatment-resistant depression. The Recover study is designed to determine whether active VNS therapy is a superior option compared to a no-stimulation control in producing a reduction in baseline symptom severity of depression. LivaNova plans to enroll […]

Filed Under: Clinical Trials, Neuromodulation/Neurostimulation Tagged With: LivaNova

LivaNova wins Medicare nod for nerve stimulation trial

September 6, 2019 By Nancy Crotti

Medicare has approved a LivaNova (NSDQ:LIVN) study of vagus nerve stimulation (VNS) to treat depression, the company said today. The Centers for Medicare and Medicaid Services accepted the London-based company’s protocol for a clinical trial to study the safety and effectiveness of adding VNS to traditional depression treatment in patients with treatment-resistant depression. Approval of […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Implants, Medicare, Neuromodulation/Neurostimulation, News Well, Wall Street Beat Tagged With: Centers for Medicare and Medicaid Services (CMS), LivaNova

LivaNova slides on Q1 misses, slashed outlook

May 1, 2019 By Brad Perriello

LivaNova (NSDQ:LIVN) shares took a hit today after the medical device maker posted first-quarter results that missed the consensus forecast and slashed its earnings outlook for the rest of the year. London-based LivaNova reported losses of -$14.8 million, or -31¢ per share, on sales of $250.8 million for the three months ended March 31. That compares […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: LivaNova

LivaNova shares plummet on prelim Q1 miss

April 5, 2019 By Fink Densford

LivaNova (NSDQ:LIVN) shares have plunged over 25% so far today after the medical device maker posted preliminary sales numbers for its first quarter that fell below expectations on Wall Street. The London-based company said that it expects to post sales of $250.5 million for the quarter, well below the Wall Street expectations of $264.6 million. The […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: LivaNova

LivaNova to settle majority of U.S. 3T Heater-Cooler cases

March 29, 2019 By Fink Densford

LivaNova (NSDQ:LIVN) said that it inked a deal to settle approximately 75% of litigations it faces in the U.S. related to its 3T Heater-Cooler device, which has been implicated in a number of unexpected severe patient infections, expecting to pay up to $225 million to settle the claims. In June 2016, the FDA warned patients […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: LivaNova

LivaNova’s CMS vagus nerve depression device trial must include sham arm

March 27, 2019 By Fink Densford

A new U.S. Centers for Medicare & Medicaid Services trial of LivaNova‘s (NSDQ:LIVN) Vagus Nerve Stimulation Therapy system intended to treat treatment-resistant depression will require a sham-control arm, doubling the subject population LivaNova originally expected. The trial, which the London-based company won clearance from CMS for last month, will allow coverage for the VNS devices […]

Filed Under: Clinical Trials, Neurological Tagged With: LivaNova

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy